To compare two drugs for reduction of propofol injection pai
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/06/034333
- Lead Sponsor
- Department of Anaesthesia Panjab institute of medical sciences Jalandhar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients posted for elective surgery
Exclusion Criteria
Patient refusal
Allergy to propofol,
egg
History of cardiovascular, respiratory dysfunction
History of difficult intubation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of cisatracurium with 2% xylocard pretreatment to reduce propofol injection painTimepoint: Single
- Secondary Outcome Measures
Name Time Method Any adverse effects (nausea , vomiting , muscle paralysis, diplopia, anaphylaxis) of cisatracurium and 2%xylocaine preservative free during study cisatracuriumTimepoint: Single;Any adverse effects,(nausea, vomiting, muscle paralysis, diplopia, anaphylaxis) of both these drugsTimepoint: Single
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cisatracurium's effect on propofol injection pain reduction?
How does 2% lignocaine preservative-free (xylocard) compare to standard analgesics for propofol injection pain?
Are there specific biomarkers that predict response to tourniquet pretreatment in reducing propofol injection pain?
What are the potential adverse events associated with cisatracurium pretreatment in clinical settings?
What alternative drug combinations or pretreatment strategies are being explored for propofol injection pain management?